Amplatzer septal occluder (AGA Med. Co., USA) is a novel device for occlusi
on of atrial septal defect. We present our experience of transcatheter clos
ure of atrial septal defects using Amplatzer septal occluder in 45 adult Ch
inese patients (age range 18-69 years). The sire of atrial septal defect va
ried from 14-28 (23 +/- 4) mm, Cardiac catheterization revealed a pulmonary
-to-systemic shunt ratio ranging from 1.4-2.8 (mean 2.0 +/- 0,4). The proce
dure was successful in 44 (98%) patients. Displacement of the device requir
ing surgical removal occurred in one (2%) patient and minor wound complicat
ion occurred in two (4%) patients. Total procedure time was 67 +/- 16 minut
es and the fluoroscopy time was 25 +/- 8 min. Immediate post-procedure and
pre-discharge echocardiography revealed complete abolition of shunt in 42 (
93%) and trivial residual shunt in 3 (7%) patients. The average follow-up p
eriod was 16 +/- 6 months (range 2 months to 3 years) months. None of the p
atients had developed other major complication at follow-up. (C) 2001 Wiley
-Liss, Inc.